Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 149Breast Neoplasms 87Colorectal Neoplasms 64Neoplasms 53Pancreatic Neoplasms 52Lung Neoplasms 49Neoplasm Metastasis 45Stomach Neoplasms 43Ovarian Neoplasms 42Rectal Neoplasms 41Esophageal Squamous Cell Carcinoma 34Esophageal Neoplasms 33Squamous Cell Carcinoma of Head and Neck 30Head and Neck Neoplasms 30Leukemia, Myeloid, Acute 28Recurrence 23Triple Negative Breast Neoplasms 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Small Cell Lung Carcinoma 20Nasopharyngeal Carcinoma 20Glioblastoma 20Uterine Cervical Neoplasms 19Fallopian Tube Neoplasms 19Lymphoma, Non-Hodgkin 18Lymphoma 18Colonic Neoplasms 17Prostatic Neoplasms 16Leukemia 15Carcinoma, Ovarian Epithelial 15Melanoma 14

Interventions

Cisplatin 7Radiotherapy 3Paclitaxel 3Carboplatin 3Brachytherapy 2zimberelimab 1piperine 1pembrolizumab 1durvalumab 1camrelizumab 1atezolizumab 1Sodium Chloride 1Neoadjuvant Therapy 1Gemcitabine 1Drug Therapy 1Curcumin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Cervical Cancer × Drug Therapy × Clear all
NCT05437692 2022-10-12

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Shanghai Zhongshan Hospital

Phase 2 Unknown
19 enrolled
Gynecologic

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡